Luley C - Search Results

1

Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability.

Orth M, Luley C, Wieland H. Orth M, et al. Among authors: luley c. Thromb Res. 1995 Aug 1;79(3):297-305. doi: 10.1016/0049-3848(95)00116-9. Thromb Res. 1995. PMID: 8533125

2

Responsiveness of atiii and coagulation factors V and VII to a standardized oral fat load.

Orth M, Luley C, Mayer H, Wieland H. Orth M, et al. Among authors: luley c. Thromb Res. 1995 Nov 1;80(3):265-70. doi: 10.1016/0049-3848(95)00175-q. Thromb Res. 1995. PMID: 8578553 No abstract available.

3

Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype.

Orth M, Wahl S, Hanisch M, Friedrich I, Wieland H, Luley C. Orth M, et al. Among authors: luley c. Biochim Biophys Acta. 1996 Sep 6;1303(1):22-30. doi: 10.1016/0005-2760(96)00075-6. Biochim Biophys Acta. 1996. PMID: 8816849

4

Fluorometric determination of total retinyl esters in triglyceride-rich lipoproteins.

Orth M, Hanisch M, Kröning G, Porsch-Ozcürümez M, Wieland H, Luley C. Orth M, et al. Among authors: luley c. Clin Chem. 1998 Jul;44(7):1459-65. Clin Chem. 1998. PMID: 9665424 Clinical Trial.

5

Effects of a frequent apolipoprotein E isoform, ApoE4Freiburg (Leu28-->Pro), on lipoproteins and the prevalence of coronary artery disease in whites.

Orth M, Weng W, Funke H, Steinmetz A, Assmann G, Nauck M, Dierkes J, Ambrosch A, Weisgraber KH, Mahley RW, Wieland H, Luley C. Orth M, et al. Among authors: luley c. Arterioscler Thromb Vasc Biol. 1999 May;19(5):1306-15. doi: 10.1161/01.atv.19.5.1306. Arterioscler Thromb Vasc Biol. 1999. PMID: 10323784

6

Hemostatic factors in hypertriglyceridemic men: effects of a fatty meal before and after triglyceride-lowering treatment with etofibrate.

Orth M, Mayer H, Halle M, Luley C. Orth M, et al. Among authors: luley c. Thromb Res. 1999 Jun 15;94(6):341-51. doi: 10.1016/s0049-3848(99)00007-9. Thromb Res. 1999. PMID: 10390129 Clinical Trial.

7

Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.

Westphal S, Orth M, Ambrosch A, Osmundsen K, Luley C. Westphal S, et al. Among authors: luley c. Am J Clin Nutr. 2000 Apr;71(4):914-20. doi: 10.1093/ajcn/71.4.914. Am J Clin Nutr. 2000. PMID: 10731497

8

Chylomicron remnant concentrations in patients with coronary artery disease.

Orth M, Dierkes J, Luley C. Orth M, et al. Among authors: luley c. Clin Chem Lab Med. 2003 May;41(5):652-62. doi: 10.1515/CCLM.2003.099. Clin Chem Lab Med. 2003. PMID: 12812263

9

The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease.

Dierkes J, Bissé E, Nauck M, Orth M, Mayer H, Luley C, Wieland H. Dierkes J, et al. Among authors: luley c. Clin Chem Lab Med. 1998 Jun;36(7):453-7. doi: 10.1515/CCLM.1998.076. Clin Chem Lab Med. 1998. PMID: 9746269

10

An improved method for the rapid assessment of persisting chylomicron remnant concentrations.

Orth M, Weinland-Wilken C, Westphal S, Luley C. Orth M, et al. Among authors: luley c. Clin Biochem. 2001 Jul;34(5):387-94. doi: 10.1016/s0009-9120(01)00233-8. Clin Biochem. 2001. PMID: 11522276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters